Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Suarez

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Frontiers in Immunology|November 7, 2022
Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 PatientsLaura E Martínez-Gómez, Isabel Ibarra-González, Cynthia Fernández-Lainez, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 26, 2023
Implication of myddosome complex genetic variants in outcome severity of COVID-19 patientsLaura E Martínez-Gómez, Carlos Martinez-Armenta, Daniel Medina-Luna, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Frontiers in Immunology|March 7, 2022
<i>ACE</i> and <i>ACE2</i> Gene Variants Are Associated With Severe Outcomes of COVID-19 in MenLaura E Martínez-Gómez, Brígida Herrera-López, Carlos Martinez-Armenta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Frontiers in Immunology|November 7, 2022
Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 PatientsLaura E Martínez-Gómez, Isabel Ibarra-González, Cynthia Fernández-Lainez, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 26, 2023
Implication of myddosome complex genetic variants in outcome severity of COVID-19 patientsLaura E Martínez-Gómez, Carlos Martinez-Armenta, Daniel Medina-Luna, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Frontiers in Immunology|March 7, 2022
<i>ACE</i> and <i>ACE2</i> Gene Variants Are Associated With Severe Outcomes of COVID-19 in MenLaura E Martínez-Gómez, Brígida Herrera-López, Carlos Martinez-Armenta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.
Pageof 16